Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
76,991,404
-
Total 13F shares
-
7,534,407
-
Share change
-
+7,534,407
-
Total reported value
-
$52,712,105
-
Price per share
-
$7.01
-
Number of holders
-
16
-
Value change
-
+$52,712,001
-
Number of buys
-
16
Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q2 2016
As of 30 Jun 2016,
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,534,407 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Cormorant Asset Management, LLC, Rock Springs Capital Management LP, PERCEPTIVE ADVISORS LLC, Hillhouse Capital Management, Ltd., SPHERA FUNDS MANAGEMENT LTD., Marshall Wace LLP, Alyeska Investment Group, L.P., Iguana Healthcare Management, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.